Nanomedicine: Nanotechnology, Biology and Medicine
Volume 4, Issue 1 , Pages 57-69 , March 2008

Fabrication of {198Au0} radioactive composite nanodevices and their use for nanobrachytherapy

  • Mohamed K. Khan, MD, PhD

      Affiliations

    • NanoBiotechnology Center at RPCI, Department of Radiation Medicine, Roswell Park Cancer Institute, Buffalo, New York
    • ,
  • Leah D. Minc, PhD

      Affiliations

    • OSU Radiation Center, Oregon State University, Corvallis, Oregon
    • ,
  • Shraddha S. Nigavekar, PhD

      Affiliations

    • Department of Radiation Oncology, University of Michigan Medical Center, Ann Arbor, Michigan
    • ,
  • Muhammed S.T. Kariapper, PhD

      Affiliations

    • NanoBiotechnology Center at RPCI, Department of Radiation Medicine, Roswell Park Cancer Institute, Buffalo, New York
    • ,
  • Bindu M. Nair, PhD

      Affiliations

    • NanoBiotechnology Center at RPCI, Department of Radiation Medicine, Roswell Park Cancer Institute, Buffalo, New York
    • ,
  • Matthew Schipper, PhD

      Affiliations

    • OSU Radiation Center, Oregon State University, Corvallis, Oregon
    • ,
  • Andrew C. Cook, PhD

      Affiliations

    • Department of Nuclear Engineering, Burlington Engineering Laboratories, North Carolina State University, Raleigh, North Carolina, USA
    • ,
  • Wojciech G. Lesniak, PhD

      Affiliations

    • NanoBiotechnology Center at RPCI, Department of Radiation Medicine, Roswell Park Cancer Institute, Buffalo, New York
    • ,
  • Lajos P. Balogh, PhD

      Affiliations

    • NanoBiotechnology Center at RPCI, Department of Radiation Medicine, Roswell Park Cancer Institute, Buffalo, New York
    • Corresponding Author InformationCorresponding author: NanoBiotechnology Center at RPCI, Department of Radiation Medicine, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, New York 14263, USA.

Received 11 April 2007 ,Accepted 26 November 2007.

References 

  1. Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, et al. Cancer statistics. Cancer J Clin. 2004;54:8–29
  2. Flocks RH, Kerr HD, Elkins HB, Culp DA. Treatment of carcinoma of the prostate by interstitial radiation with radioactive gold: a preliminary report. J Urol. 1952;68:510–522
  3. Loening SA. Gold seed implantation in prostate brachytherapy. Semin Surg Oncol. 1997;13:419–424
  4. Balogh L, Laverdure KS, Gido SP, Mott AG, Miller MJ, Ketchel BP, et al. Organic/inorganic hybrid materials Mat. Res Soc Symp Proc. 1999;576:69–75
  5. Esumi K, Suzuki A, Aihara N, Usui K, Torigoe K. Preparation of gold colloids with UV irradiation using dendrimers as stabilizer. Langmuir. 1998;14:3157–3159
  6. Garcia ME, Baker LA, Crooks RM. Preparation and characterization of dendrimer-gold colloid nanocomposites. Anal Chem. 1999;71:256–258
  7. Tomalia DA, Balogh L. Nanocomposites of dendritic polymers. United States patent US 6664315 B2. December 16, 2003.
  8. Tomalia DA, Balogh L. Nanocomposites of dendritic polymers. United States patent US 6995234. February 7, 2006.
  9. Balogh L, Tomalia DA, Hagnauer GL. Revolution of nanoscale proportions. Chem Innov. 2000;30:9–26
  10. Lesniak W, Bielinska AU, Sun K, Janczak KW, Shi X, Baker JR, et al. Silver/dendrimer nanocomposites as biomarkers: fabrication, characterization, in vitro toxicity, and intracellular detection. Nano Lett. 2005;5:2123–2130
  11. Kukowska-Latallo JF, Candido KA, Cao Z, Nigavekar SS, Majoros IJ, Thomas TP, et al. Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer. Cancer Res. 2005;65:5317–5324
  12. Khan MK, Nigavekar SS, Minc LD, Kariapper MST, Nair BM, Lesniak WG, et al. Biodistribution of dendrimers and dendrimer nanocomposites: implications for cancer imaging and therapy. Technol Cancer Res Treat. 2005;4:603–613
  13. Nigavekar SS, Sung LY, Llanes M, El-Jawahri A, Lawrence TS, Becker CW, et al. 3H dendrimer nanoparticle organ/tumor distribution. Pharm Res. 2004;21:476–483
  14. Grohn F, Bauer BJ, Akpalu YA, Jackson CL, Amis EJ. Dendrimer templates for the formation of gold nanoclusters. Macromolecules. 2000;33:6042–6050
  15. Folkman J. Tumor angiogenesis. In:  Holland JF,  Frei E,  Bast RC,  Kufe DW,  Morton DL,  Weichselbaum RR editor. Cancer medicine. 4th ed.. Baltimore, MD: Williams & Wilkins; 1996;p. 181–204
  16. Ribatti D, Vacca A, Dammacco F. The role of the vascular phase in solid tumor growth: a historical review. Neoplasia. 1999;1:293–302
  17. Schlingemann RO, Rietveld FJ, Kwaspen F, van de Kerkhof PC, de Waal RM, Ruiter DJ. Differential expression of markers for endothelial cells, pericytes, and basal lamina in the microvasculature of tumors and granulation tissue. Am J Pathol. 1991;138:1335–1347
  18. Jain RK. Determinants of tumor blood flow: a review. Cancer Res. 1988;48:2641–2658
  19. Matsumura Y, Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent Smancs. Cancer Res. 1986;46:6387–6392
  20. Duncan R, Malik N, Richardson S, Ferruti P. Polymer conjugates for anti-cancer agent and DNA delivery. Polym Prepr Am Chem Soc Div Polym Chem. 1998;39:180–181
  21. Muggia FM. Doxorubicin-polymer conjugates: further demonstration of the concept of enhanced permeability and retention. Clin Cancer Res. 1999;5:7–8
  22. Balogh LP, Nigavekar SS, Cook AC, Minc L, Khan MK. Development of dendrimer-gold radioactive nanocomposites to treat cancer microvasculature. PharmaChem. 2003;2:94–99
  23. Balogh L, Valuzzi R, Laverdure KS, Gido SP, Hagnauer GL, Tomalia DA. Formation of silver and gold dendrimer nanocomposites. J Nanoparticle Res. 1999;1:353–368
  24. Seo YS, Kim KS, Shin K, White H, Rafailovich M, Sokolov J, et al. Morphology of amphiphilic gold/dendrimer nanocomposite monolayers. Langmuir. 2002;18:5927–5932
  25. Uppuluri S, Swanson DR, Brothers HM, Piehler LT, Li J, Meier DJ, et al Tecto(dendrimer) core-shell molecules: macromolecular tectonics for the systematic synthesis of larger controlled structure molecules. Polym Mater Sci Eng. 1999;80:55–56
  26. Tomalia DA, Brothers HM, Piehler LT, Durst HD, Swanson DR. Partial shell-filled core-shell tecto(dendrimers): a strategy to surface differentiated nano-clefts and cusps. Proc Natl Acad Sci USA. 2002;99:5081–5087
  27. Tomalia DA, Uppuluri S, Swanson DR, Li J. Dendrimers as reactive modules for the synthesis of new structure-controlled, higher-complexity megamers. Pure Appl Chem. 2000;72:2343–2358
  28. Shaw IC. Gold-based therapeutic agents. Chem Rev. 1999;99:2589–2600
  29. El-Sayed IH, Huang X, El-Sayed MA. Selective laser photo-thermal therapy of epithelial carcinoma using anti-EGFR antibody conjugated gold nanoparticles. Cancer Lett. 2006;239:129–135
  30. Hirsch LR, Stafford RJ, Bankson JA, Sershen SR, Rivera B, Price RE, et al. Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance. Proc Natl Acad Sci USA. 2003;100:13549–13554
  31. Loo C, Lin A, Hirsch L, Lee M, Barton J, Halas N, et al. Nanoshell enabled photonics-based imaging and therapy of cancer. Technol Cancer Res Treat. 2004;3:33–40
  32. Loo C, Lowery A, Halas N, West J, Drezek R. Immunotargeted nanoshells for integrated cancer imaging and therapy. Nano Lett. 2005;5:709–711
  33. Hainfeld JF, Foley CJ, Srivastava SC, Mausner LF, Feng NI, Meinken GE, et al. Radioactive gold cluster immunoconjugates: potential agents for cancer therapy. Int J Radiat Appl Instrum. 1990;17:287–294
  34. O'Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M, et al. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell. 1994;79:315–328
  35. Cotton FA, Murillo CA, Bochmann M. Advanced inorganic chemistry. 4th ed.. New York: Wiley; 1999;
  36. Esumi K. Dendrimers for nanoparticle synthesis and dispersion stabilization. Topics Curr Chem. 2003;227:31–52
  37. Lee WI, Bae Y, Bard AJ. Strong blue photoluminescence and ECL from OH-terminated PAMAM dendrimers in the absence of gold nanoparticles. J Am Chem Soc. 2004;126:8358–8359
  38. Esumi K, Suzuki A, Yamahira A, Torigoe K. Role of poly(amidoamine) dendrimers for preparing nanoparticles of gold, platinum, and silver. Langmuir. 2000;16:2604–2608
  39. Bielinska A, Eichman JD, Lee I, Baker JR, Balogh L. Imaging {Au0-PAMAM} gold-dendrimer nanocomposites in cells. J Nanoparticle Res. 2002;4:395–403
  40. Tang MX, Redemann CT, Szoka FC. Gene delivery by degraded polyamidoamine dendrimers. Bioconjug Chem. 1996;7:703–714
  41. Burda C, Chen X, Narayanan R, El-Sayed MA. Chemistry and properties of nanocrystals of different shapes. Chem Rev. 2005;105:1025–1102
  42. Rosi NL, Mirkin CA. Nanostructures in biodiagnostics. Chem Rev. 2005;105:1547–1562
  43. Balogh LP, Khan MK. Dendrimer nanocomposites for cancer therapy. In:  Amiji M editors. Nanotechnology in cancer therapy. Boca Raton (FL): CRC Press (Taylor and Francis Group); 2006;p. 551–592

PII: S1549-9634(07)00252-3

doi: 10.1016/j.nano.2007.11.005

Nanomedicine: Nanotechnology, Biology and Medicine
Volume 4, Issue 1 , Pages 57-69 , March 2008

Article Tools

* Image Usage & Resolution